600998 Stock Overview
Provides pharmaceutical supply chain services in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Jointown Pharmaceutical Group Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.22 |
| 52 Week High | CN¥6.94 |
| 52 Week Low | CN¥4.35 |
| Beta | 0.19 |
| 1 Month Change | 0.77% |
| 3 Month Change | -0.57% |
| 1 Year Change | -4.21% |
| 3 Year Change | -2.32% |
| 5 Year Change | 0.48% |
| Change since IPO | -25.99% |
Recent News & Updates
Recent updates
We Think Jointown Pharmaceutical Group (SHSE:600998) Can Stay On Top Of Its Debt
Nov 17
Here's What Analysts Are Forecasting For Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Following Its Earnings Miss
Aug 29Earnings Working Against Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Share Price
Aug 26These 4 Measures Indicate That Jointown Pharmaceutical Group (SHSE:600998) Is Using Debt Reasonably Well
Aug 01Jointown Pharmaceutical Group (SHSE:600998) Has More To Do To Multiply In Value Going Forward
Jun 07Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Earnings Are Not Doing Enough For Some Investors
May 21Calculating The Intrinsic Value Of Jointown Pharmaceutical Group Co., Ltd (SHSE:600998)
Apr 05Shareholder Returns
| 600998 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -3.3% | -2.4% | -0.5% |
| 1Y | -4.2% | -11.6% | 9.2% |
Return vs Industry: 600998 exceeded the CN Healthcare industry which returned -9.2% over the past year.
Return vs Market: 600998 underperformed the CN Market which returned 10.8% over the past year.
Price Volatility
| 600998 volatility | |
|---|---|
| 600998 Average Weekly Movement | 5.7% |
| Healthcare Industry Average Movement | 8.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600998 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600998's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 30,100 | Wei He | www.jztey.com |
Jointown Pharmaceutical Group Co., Ltd provides pharmaceutical supply chain services in China. It is also involved in general agency brand promotion; digital retail; intelligent logistics and supply chain solutions; and medical health and technology value-added service businesses. In addition, the company manufactures western medicines, such as antibiotics, anti-diabetic drugs, and cardiovascular drugs; and other OEM medicines.
Jointown Pharmaceutical Group Co., Ltd Fundamentals Summary
| 600998 fundamental statistics | |
|---|---|
| Market cap | CN¥25.64b |
| Earnings (TTM) | CN¥2.05b |
| Revenue (TTM) | CN¥149.20b |
12.5x
P/E Ratio0.2x
P/S RatioIs 600998 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600998 income statement (TTM) | |
|---|---|
| Revenue | CN¥149.20b |
| Cost of Revenue | CN¥137.45b |
| Gross Profit | CN¥11.75b |
| Other Expenses | CN¥9.70b |
| Earnings | CN¥2.05b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.42 |
| Gross Margin | 7.88% |
| Net Profit Margin | 1.37% |
| Debt/Equity Ratio | 43.1% |
How did 600998 perform over the long term?
See historical performance and comparisonDividends
3.7%
Current Dividend Yield48%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 03:43 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jointown Pharmaceutical Group Co., Ltd is covered by 19 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shaoling Wang | Chasing Securities |
| Fusheng Cheung | China Galaxy International Securities (Hong Kong) |
| Pei Cheng | China Galaxy Securities Co., Ltd. |